Arkansas Child Abuse/Rape/Domestic Violence Commission issued the following announcement on Dec. 4.
“This is one of the largest studies of cancer prevention among persons living with HIV, & it offers an opportunity for these individuals to reduce their risk of anal cancer through removal of precancerous lesions,” said Dr. Jeannette Y. Lee.
ecently halted due to its high success rate, the randomized clinical trial of 4,446 participants found that by removing high-grade squamous intraepithelial lesions (HSIL), chances of progression to anal cancer were significantly reduced.
The trial is the first to show such findings and was performed at 21 clinical sites around the United States. Results are being prepared for peer-reviewed publication and are being shared now because of the public health importance of the findings.
Original source can be found here.
Source: Arkansas Child Abuse/Rape/Domestic Violence Commission
Alerts Sign-up